A total of 377 Chinese companies debuted on the Shanghai and Shenzhen stock exchanges so far this ... The result echoes the earlier report by Xinmin Evening News that the number of IPO would be 352 as of the middle of October, a new high compared to ... ( read original story ...)
Shanghai Pharma buys U.S. Cardinal Health’s China business for $557 mln
The deal will also help Shanghai Pharma, China's third largest drug distributor, become a leading importer of foreign medicine into the world's second-largest drug market. By comparison, Shanghai Pharma, which is backed by the Shanghai government ... ( read original story ...)
AnalogFolk Launches Office in Shanghai Led by Wayne Fan and Tommy Liou
Independent digital creative agency AnalogFolk is opening an office in Shanghai, marking the sixth in its network. The new office will be led by managing director and partner Wayne Fan and creative director and partner Tommy Liou, and launches as a ... ( read original story ...)
China gov’t bond yields at 3-year high amid market ‘misery’
SHANGHAI, Nov 14 (Reuters ... Concerns over slowing growth and rising yields on government debt spread to the country's stock market, with China's blue-chip index falling 0.7 percent by Tuesday afternoon. Analysts say that in the near term, the bond ... ( read original story ...)
Phishing e-mail related to The Hongkong and Shanghai Banking Corporation Limited
The following is issued on behalf of the Hong Kong Monetary Authority: The Hong Kong Monetary Authority (HKMA) wishes to alert members of the public to a press release issued by The Hongkong and Shanghai Banking Corporation Limited on phishing e-mail ... ( read original story ...)
Shanghai positions itself as China’s AI hub
SHANGHAI (CHINA DAILY/ASIA NEWS NETWORK) - Shanghai is looking to become China's hot-spot for artificial intelligence (AI) and wants to expand the industry scale in the city to more than 100 billion yuan (S$20.5 million) by 2020, according to a new ... ( read original story ...)
Shanghai Pharmaceuticals buys out Cardinal Health in China to become top distributor of imported drugs
Liu expects Shanghai Pharmaceuticals Holding’s investment in Cardinal to reap a return in eight to nine years. With a rapidly ageing population, the Chinese government has issued several new industry policies in an attempt to reform and improve the ... ( read original story ...)